State of Wyoming’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,229
Closed -$23.2K 1739
2023
Q1
$23.2K Sell
1,229
-1,246
-50% -$27.6K 0.01% 1392
2022
Q4
$56.1K Sell
2,475
-1,418
-36% -$32.1K 0.02% 1031
2022
Q3
$103K Buy
3,893
+2,704
+227% +$80.2K 0.05% 583
2022
Q2
$29K Buy
1,189
+455
+62% +$11.4K 0.02% 1281
2022
Q1
$24K Buy
734
+247
+51% +$6.86K 0.01% 1387
2021
Q4
$16K Buy
487
+69
+17% +$2.35K 0.01% 1573
2021
Q3
$18K Sell
418
-298
-42% -$10.7K 0.01% 957
2021
Q2
$28K Buy
716
+459
+179% +$16.4K 0.02% 869
2021
Q1
$9K Buy
+257
New +$11K 0.01% 399

Other funds holding RGNX

State of Wyoming's RGNX Position: Q2 2023 in Review

State of Wyoming sold out of Regenxbio (RGNX) in Q2 2023, closing a stake of 1,229 shares — an estimated $23.2K sold.

State of Wyoming first reported a position in RGNX in Q1 2021 and held it in 9 quarters. The position peaked at $103K in Q3 2022. 167 funds tracked by Wall St. Rank hold RGNX as of Q2 2023.

  • State of Wyoming reported no remaining Regenxbio position as of Q2 2023 after selling out during the quarter.
  • State of Wyoming sold 1,229 Regenxbio shares in Q2 2023, an estimated $23.2K.
  • State of Wyoming first reported a position in Regenxbio in Q1 2021 and held it in 9 quarters.
  • State of Wyoming's Regenxbio position peaked at $103K in Q3 2022.
  • 167 funds tracked by Wall St. Rank held Regenxbio as of Q2 2023.

Based on State of Wyoming's 13F filing for Q2 2023, filed 14 Aug 2023.